Recently, Lu and colleagues combined an IDO inhibitor indocimod with the ICD inducer OXA in lipid-coated mesoporous silica nanoparticles, achieving the inhibition of tumor growth in a mouse model of pancreatic ductal adenocarcinoma and significantly prolonging the survival period of mice with tumors (Lu et al., 2017). The gene discussed is IDO1; the disease is neoplasm.